Streetbeat News

WELL

Welltower Inc.

https://www.welltower.com

Industry

REIT - Healthcare Facilities

Welltower Inc. (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower, a real estate investment trust ("REIT"), owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties.

Open

137.11

Mkt cap

85B

Volume

77K

High

137.44

P/E Ratio

87.50

52-wk high

140.19

Low

136.50

Div yield

0.02

52-wk low

85.40

Deutsche Bank analyst Omotayo Okusanya has initiated coverage on Welltower (NYSE:WELL) with a Buy rating and set a price target of $115.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 12:04 pm

Welltower (NYSE:WELL) has seen a 3.65% increase in short interest since the last report, with 7.57 million shares sold short, representing 1.99% of available shares. It would take about 3.63 days to cover all short positions. While an increase in short interest can indicate bearish sentiment, Welltower has less short interest compared to its peer group average of 5.74%. The rise in short interest doesn't necessarily predict a stock price fall.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 1:15 pm

Welltower (NYSE:WELL) has delivered an average annual return of 16.43% over the past 15 years, outperforming the market by 4.5% annually. A $100 investment in WELL 15 years ago would be worth $1,051.30 today. The company's current market capitalization stands at $48.99 billion.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 7:30 pm

Keybanc analyst Todd Thomas has maintained an Overweight rating on Welltower (NYSE:WELL) and increased the price target from $90 to $95.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 10:21 am

Welltower (NYSE:WELL) has been evaluated by 8 financial analysts over the last three months, with a mix of bullish to bearish sentiments. The average 12-month price target is $94.88, up 5.76% from the previous $89.71. Analysts from firms like Mizuho, JP Morgan, RBC Capital, Evercore ISI Group, Wells Fargo, Raymond James, and Keybanc have raised their price targets, reflecting a positive outlook. Welltower's financials show a strong market presence, solid revenue growth, but challenges in profitability and return on equity, while excelling in asset utilization and maintaining a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 6:00 pm

Mizuho analyst Omotayo Okusanya has reaffirmed a Buy rating on Welltower (NYSE:WELL) and increased the price target from $90 to $98, signaling confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 3:42 pm

Over the past 15 years, Welltower (NYSE:WELL) has produced an average annual return of 16.26%, outperforming the market. A $1000 investment in WELL 15 years ago would be worth $9,718.14 today. Welltower currently has a market cap of $49.80 billion.

Portfolio Pulse from Benzinga Insights

December 26, 2023 | 3:30 pm

Welltower (NYSE:WELL) has received updated ratings and price targets from 9 financial analysts in the last quarter. The average 12-month price target is $93.22, with a high of $101.00 and a low of $83.00. The ratings are mostly bullish or neutral, with 1 bullish, 4 somewhat bullish, and 4 indifferent. Notably, the average price target has increased by 3.91% over the past month. Welltower's financial health indicators show a strong market presence, positive revenue trend, but below-average net margin and ROE, with an exceptional ROA and a balanced debt approach.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 9:01 pm

Welltower (NYSE:WELL) received 9 analyst ratings in the last quarter, with an average 12-month price target of $93.22, a high of $101.00, and a low of $83.00. The current average reflects a 3.91% increase from the previous average of $89.71. Analysts from firms like JP Morgan, RBC Capital, and Raymond James have raised their price targets, indicating a positive sentiment towards Welltower's stock. The company has shown a positive revenue trend with a growth rate of 12.77% as of September 30, 2023, but has a net margin and ROE below industry averages, although its ROA and debt management are strong.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 3:39 pm

JP Morgan analyst Michael Mueller has upgraded Welltower (NYSE:WELL) from Neutral to Overweight and increased the price target from $92 to $99.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 10:21 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.